These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25318476)

  • 1. Equipment and method for in vitro release measurements on topical dosage forms.
    Sesto Cabral ME; Ramos AN; Cabrera CA; Valdez JC; González SN
    Pharm Dev Technol; 2015; 20(5):619-25. PubMed ID: 25318476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different test parameters on in vitro drug release from topical diclofenac formulations in a vertical diffusion cell setup.
    Klein S
    Pharmazie; 2013 Jul; 68(7):565-71. PubMed ID: 23923638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2018 Jan; 535(1-2):217-227. PubMed ID: 28935255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release from semisolid dosage forms: a comparison of two testing methods.
    Petró É; Paál TL; Erős I; Kenneth AS; Baki G; Csóka I
    Pharm Dev Technol; 2015 May; 20(3):330-6. PubMed ID: 24328512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
    Bao Q; Burgess DJ
    Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.
    Shah VP; Elkins JS; Williams RL
    Pharm Dev Technol; 1999 Aug; 4(3):377-85. PubMed ID: 10434283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced topical formulations (ATF).
    Hadgraft J; Lane ME
    Int J Pharm; 2016 Nov; 514(1):52-57. PubMed ID: 27260130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2014 Aug; 15(4):994-9. PubMed ID: 24824173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of drug release from ointments: Role of transient-boundary layer.
    Xu X; Al-Ghabeish M; Krishnaiah YS; Rahman Z; Khan MA
    Int J Pharm; 2015 Oct; 494(1):31-9. PubMed ID: 26241753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release of nitroglycerin from topical products by use of artificial membranes.
    Wu ST; Shiu GK; Simmons JE; Bronaugh RL; Skelly JP
    J Pharm Sci; 1992 Dec; 81(12):1153-6. PubMed ID: 1491329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms.
    Hauck WW; Shah VP; Shaw SW; Ueda CT
    Pharm Res; 2007 Nov; 24(11):2018-24. PubMed ID: 17530388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New easy handling and sampling device for bioavailability screening of topical formulations.
    Salmon D; Gilbert E; Gioia B; Haftek M; Pivot C; Verrier B; Pirot F
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():23-9. PubMed ID: 26083671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release testing method development for ophthalmic ointments.
    Bao Q; Shen J; Jog R; Zhang C; Newman B; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2017 Jun; 526(1-2):145-156. PubMed ID: 28461266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microencapsulation of citronella oil for mosquito-repellent application: formulation and in vitro permeation studies.
    Solomon B; Sahle FF; Gebre-Mariam T; Asres K; Neubert RH
    Eur J Pharm Biopharm; 2012 Jan; 80(1):61-6. PubMed ID: 21924356
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kulkarni M; Potdar S; Date AA; Marfatiya A
    Assay Drug Dev Technol; 2021; 19(2):75-84. PubMed ID: 33035072
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biorelevant in vitro release/permeation system for oral transmucosal dosage forms.
    Delvadia PR; Barr WH; Karnes HT
    Int J Pharm; 2012 Jul; 430(1-2):104-13. PubMed ID: 22486954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution.
    Zhou Y; He C; Chen K; Ni J; Cai Y; Guo X; Wu XY
    J Control Release; 2016 Dec; 243():11-20. PubMed ID: 27693750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution methodology for taste masked oral dosage forms.
    Gittings S; Turnbull N; Roberts CJ; Gershkovich P
    J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
    Stanković M; Frijlink HW; Hinrichs WL
    Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.